Phibro Animal Health Corporation
Organization details
- Legal name
- Phibro Animal Health Corporation
- Former names
- Philipp Brothers Chemicals Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Teaneck
- Headquarters state / province
- New Jersey
- Headquarters country
- United States
- Fiscal year end
- June
- Ticker symbol
- PAHC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001069899
- EIN
- 13-1840497
Board of directors
-
Alejandro Bernal · DirectorSince 2023
-
Daniel M. Bendheim · Director · President and CEOSince 2025
-
E. Thomas Corcoran · DirectorSince 2024
-
Jack Bendheim · Director · Executive ChairmanSince 2025
-
Jonathan Bendheim · DirectorSince 2025
-
Joyce J. Lee · DirectorSince 2025
Chief executives
Director election results
Annual meeting of November 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
97.7%
-
98.1%
Board connections
1 of this board's directors also sit on 1 other board.
- via Joyce J. Lee
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $317,700
- 1 purchase by 1 insider
- Sold, last 12 months
- $24,364,906
- 96 sales by 1 insider
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Jack Bendheim Director, Officer (Executive Chairman), 10% owner | Grant or award | +12,103 | — | — |
| Aug 6, 2026 | Jonathan Bendheim Director | Grant or award | +2,716 | — | — |
| Aug 6, 2026 | Daniel M. Bendheim Director, Officer (President and CEO) | Grant or award | +11,699 | — | — |
| Aug 6, 2026 | David Glenn Officer (Chief Financial Officer) | Grant or award | +3,334 | — | — |
| Aug 6, 2026 | Escudero Lisa Ann Officer (See Remarks) | Grant or award | +1,547 | — | — |
| Aug 6, 2026 | Miller Larry Lee Officer (Chief Operating Officer) | Grant or award | +3,522 | — | — |
| Aug 6, 2026 | Weinstein Judith Officer (See Remarks) | Grant or award | +2,478 | — | — |
| Aug 6, 2026 | Rodriguez Patrick Officer (VP Finance and Treasurer) | Grant or award | +1,503 | — | — |
| Aug 4, 2026 | Jack Bendheim Director, Officer (Executive Chairman), 10% owner | Other | −2,303 | $36.60 | $84,290 |
| Aug 4, 2026 | Daniel M. Bendheim Director, Officer (President and CEO) | Other | −486 | $36.60 | $17,788 |
| Aug 4, 2026 | David Glenn Officer (Chief Financial Officer) | Other | −840 | $36.60 | $30,744 |
| Aug 4, 2026 | Escudero Lisa Ann Officer (See Remarks) | Other | −265 | $36.60 | $9,699 |
| Aug 4, 2026 | Miller Larry Lee Officer (Chief Operating Officer) | Other | −635 | $36.60 | $23,241 |
| Aug 4, 2026 | Weinstein Judith Officer (See Remarks) | Other | −472 | $36.60 | $17,275 |
| May 29, 2026 | E. Thomas Corcoran Director | Open-market purchase | +10,000 | $31.77 | $317,700 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Phibro Animal Health Corporation
Who is the CEO of Phibro Animal Health Corporation?
Jack Bendheim is Phibro Animal Health Corporation's President and CEO.
How many directors are on Phibro Animal Health Corporation's board?
Phibro Animal Health Corporation's board has 6 directors: Alejandro Bernal, Daniel M. Bendheim, E. Thomas Corcoran, Jack Bendheim, Jonathan Bendheim and Joyce J. Lee.
Are Phibro Animal Health Corporation insiders buying or selling shares?
Over the last 12 months, Phibro Animal Health Corporation insiders bought $317,700 of shares in 1 purchase and sold $24.4 million of shares in 96 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="phibro-animal-health-corporation"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.